Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

GRN-529 has antidepressant, anxiolytic and analgesic effects in vivo

Nov. 24, 2010

Phase Ia trial demonstrates safety of SGN-70 in healthy subjects

Nov. 24, 2010

EVX-001688 improves spatial memory in young and aged rats

Nov. 24, 2010

Experiments illuminate mechanism of action of CXB-909

Nov. 23, 2010

D-3263 HCl may stabilize disease in patients with advanced prostate cancer

Nov. 23, 2010

CTAP-201 shows promise in patients with secondary hyperparathyroidism on hemodialysis

Nov. 23, 2010

First-in-human data presented on OMP-21M18 in solid tumors

Nov. 23, 2010

HM-A42 ameliorates disease symptoms in models of asthma, RA and MS

Nov. 23, 2010

Solithromycin shows potential against Plasmodium spp. and Mycobacterium leprae

Nov. 23, 2010

Promising new antimalarial candidates investigated in preclinical testing

Nov. 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....